Transient Coeliac Disease Specific Antibodies in Systemic Lupus Erythematosus: Case Report

Mihaela Spârchez^1, , Alexandru Pîrvan^{1, 2}, Nicolae Miu¹, Gabriel Samasca^{2, 3}, Bianca Simionescu^{1, 2} and Simona Rednic⁴

¹2nd Department of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

²2nd Pediatric Clinic, Emergency Clinical Hospital for Children, Cluj-Napoca, Romania

³Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

⁴Department of Rheumatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Cite this paper:
Mihaela Spârchez, Alexandru Pîrvan, Nicolae Miu, Gabriel Samasca, Bianca Simionescu and Simona Rednic. Transient Coeliac Disease Specific Antibodies in Systemic Lupus Erythematosus: Case Report. International Journal of Celiac Disease. 2015; 3(1):37-39. doi: 10.12691/ijcd-3-1-9

Abstract

The prevalence of coeliac disease (CD) in systemic lupus erythematosus (SLE) is unclear since evidence of this co -association is scarce. Furthermore, CD -specific antibodies have been described in patients with SLE without biopsy -confirmed CD. Here we describe the diagnostic challenges of CD in a patient suffering from SLE and secondary antiphospholipid syndrome, with transient positive serum levels of CD -specific antibodies, with an increased genetic risk for CD, demonstrated by HLA-DQ2 positivity. Guidance is still needed for the CD diagnosis in some atypical conditions.

Keywords:
systemic lupus erythematosus children anti-tissue transglutaminase antibodies antiendomysial antibodies

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Salardi S, Volta U, Zucchini S, Fiorini E, Maltoni G, Vaira B, et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990 s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr 2008; 46(5): 612-614.
[2]	Hansen D, Brock-Jacobsen B, Lund E, Bjørn C, Hansen LP, Nielsen C, et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up. Diabetes Care 2006; 29(11): 2452-2456.
[3]	Valentino R, Savastano S, Tommaselli AP, Dorato M, Scarpitta MT, Gigante M, et al. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm Res 1999; 51(3): 124-127.
[4]	Lepore L, Martelossi S, Pennesi M, Falcini F, Ermini ML, Ferrari R, et al. Prevalence of celiac disease in patients with juvenile chronic arthritis. J Pediatr 1996; 129(2): 311-313.
[5]	Caprai S, Vajro P, Ventura A, Sciveres M, Maggiore G. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008; 6(7): 803-806.
[6]	Koehne V de B, Bahia M, Lanna CC, Pinto MR, Bambirra EA, Cunha AS. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Arq Gastroenterol 2010; 47(3): 250-256.
[7]	Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF. Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol 2012; 39(10): 1964-1970.
[8]	Freeman HJ. Adult celiac disease followed by onset of systemic lupus erythematosus. J Clin Gastroenterol 2008; 42(3): 252-255.
[9]	Hadjivassiliou M, Sanders DS, Grünewald R a, Akil M. Gluten sensitivity masquerading as systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1501-1503.
[10]	Marai I, Shoenfeld Y, Bizzaro N, Villalta D, Doria A, Tonutti E, et al. IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. Lupus 2004; 13(4): 241-244.
[11]	Shamir R, Shoenfeld Y, Blank M, Eliakim R, Lahat N, Sobel E, et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus 2003; 12(5): 394-399.
[12]	Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54(1): 136-160.
[13]	Grainge MJ, West J, Solaymani-Dodaran M, Card TR, Logan RFA. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2012; 35(6): 730-739.
[14]	Admou B, Essaadouni L, Krati K, Zaher K, Sbihi M, Chabaa L, et al. Atypical celiac disease: from recognizing to managing. Gastroenterol Res Pract 2012; 2012: 637187.